InsiderTrades.com logo

ZIVO Insider Trading

Insider Ownership Percentage: 48.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

ZIVO Bioscience Insider Trading History Chart

This chart shows the insider buying and selling history at ZIVO Bioscience by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ZIVO Bioscience Share Price & Price History

Current Price: $2.40
Price Change: ▼ Price Decrease of -0.8 (-25.00%)
As of 04/10/2026 04:21 PM ET

This chart shows the closing price history over time for ZIVO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ZIVO Bioscience Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/2/2023Mark E StromeMajor ShareholderBuy40,000$4.99$199,600.00203,601View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for ZIVO Bioscience (NASDAQ:ZIVO)

12.83% of ZIVO Bioscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

ZIVO Bioscience Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Armistice Capital LLC801,870$1.04M0.0%-21.7%46.084%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ZIVO Bioscience logo
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
Read More on ZIVO Bioscience

Today's Range

Now: $2.40
Low: $2.36
High: $3.05

50 Day Range

MA: $8.40
Low: $2.40
High: $10.75

52 Week Range

Now: $2.40
Low: $2.36
High: $20.00

Volume

8,325 shs

Average Volume

2,504 shs

Market Capitalization

$9.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of ZIVO Bioscience?

ZIVO Bioscience's top insider investors include:
  1. Christopher D Maggiore (Director)
  2. Hep Investments Llc (Major Shareholder)
  3. Mark E Strome (Major Shareholder)
  4. Nola E Masterson (Director)
  5. Andrew A Dahl (CEO)
  6. Christopher D Maggiore (Major Shareholder)
  7. John Bernard Payne (Director)
  8. Nola E Masterson (Director)
Learn More about top insider investors at ZIVO Bioscience.

ZIVO Bioscience Active Insiders

Nola E. Masterson
Nola E. Masterson
Director
Christopher D Maggiore
Director
John Bernard Payne (Age 78)
Director